OVARIAN-FUNCTION AND ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER

被引：0
|
作者：
STOLL, BA
机构：
来源：
LANCET | 1978年 / 1卷 / 8074期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1159 / 1159
页数：1
相关论文
共 50 条
  • [1] OVARIAN-FUNCTION AND RECURRENCES WITH ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    SCHMIDTGOLLWITZER, K
    SCHONEGG, W
    SCHEIBER, A
    WESSEL, J
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1987, 47 (10) : 695 - 699
  • [2] OVARIAN-FUNCTION AND ADJUVANT CHEMOTHERAPY FOR EARLY BREAST-CANCER
    PADMANABHAN, N
    WANG, DY
    MOORE, JW
    RUBENS, RD
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06): : 745 - 748
  • [3] OVARIAN-FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    ROSE, DP
    DAVIS, TE
    LANCET, 1977, 1 (8023): : 1174 - 1176
  • [4] CYCLIC OVARIAN-FUNCTION AND BREAST-CANCER
    SHERMAN, BM
    WALLACE, RB
    BEAN, JA
    CANCER RESEARCH, 1982, 42 (08) : 3286 - 3288
  • [5] EFFECT OF CYTOSTATIC THERAPY FOR BREAST-CANCER ON OVARIAN-FUNCTION
    PFEIFFER, D
    TSUTSULOPULOS, C
    EIERMANN, W
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 325 - 325
  • [6] EFFECT OF ADJUVANT CHEMOTHERAPY ON ENDOCRINE FUNCTION IN BREAST-CANCER
    DAVIS, TE
    ROSE, DP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 49 - 49
  • [7] Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
    Moore, Halle C. F.
    Unger, Joseph M.
    Phillips, Kelly-Anne
    Boyle, Frances
    Hitre, Erika
    Porter, David
    Francis, Prudence A.
    Goldstein, Lori J.
    Gomez, Henry L.
    Vallejos, Carlos S.
    Partridge, Ann H.
    Dakhil, Shaker R.
    Garcia, Agustin A.
    Gralow, Julie
    Lombard, Janine M.
    Forbes, John F.
    Martino, Silvana
    Barlow, William E.
    Fabian, Carol J.
    Minasian, Lori
    Meyskens, Frank L., Jr.
    Gelber, Richard D.
    Hortobagyi, Gabriel N.
    Albain, Kathy S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (10): : 923 - 932
  • [8] Goserelin for Ovarian Protection During Breast-Cancer Adjuvant Chemotherapy
    Moore, Halle C. F.
    Unger, Joseph M.
    Phillips, Kelly-Anne
    Boyle, Frances
    Hitre, Erika
    Porter, David
    Francis, Prudence A.
    Goldstein, Lori J.
    Gomez, Henry L.
    Vallejos, Carlos S.
    Partridge, Ann H.
    Dakhil, Shaker R.
    Garcia, Agustin A.
    Gralow, Julie
    Lombard, Janine M.
    Forbe, John F.
    Martino, Silvana
    Barlow, William E.
    Fabian, Carol J.
    Minasian, Lori
    Meyskens, Frank L., Jr.
    Gelber, Richard D.
    Hortobagyi, Gabriel N.
    Albain, Kathy S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2015, 70 (06) : 392 - +
  • [9] ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    BUZDAR, AU
    HORTOBAGYI, GN
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (17): : 2296 - 2296
  • [10] BREAST-CANCER - ADJUVANT CHEMOTHERAPY
    RUSSO, J
    SCIENCE, 1985, 230 (4728) : 886 - 886
12345